Highbridge Capital Management’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-6,800
Closed -$254K 1602
2017
Q4
$254K Buy
+6,800
New +$346K ﹤0.01% 1347
2016
Q2
Sell
-78,200
Closed -$3.22M 1667
2016
Q1
$3.22M Buy
+78,200
New +$3.06M 0.05% 398
2015
Q4
Sell
-32,700
Closed -$1.48M 1740
2015
Q3
$1.48M Buy
32,700
+23,000
+237% +$1.34M 0.02% 643
2015
Q2
$511K Buy
+9,700
New +$383K 0.01% 960

Other funds holding PRTA

Highbridge Capital Management's PRTA Position: Q3 2016 in Review

Highbridge Capital Management sold out of Prothena Corp (PRTA) in Q3 2016, closing a stake of 13,619 shares — an estimated $476K sold.

Highbridge Capital Management first reported a position in PRTA in Q3 2014 and held it in 4 quarters. The position peaked at $1.06M in Q3 2015. 146 funds tracked by Wall St. Rank hold PRTA as of Q3 2016.

  • Highbridge Capital Management reported no remaining Prothena Corp position as of Q3 2016 after selling out during the quarter.
  • Highbridge Capital Management sold 13,619 Prothena Corp shares in Q3 2016, an estimated $476K.
  • Highbridge Capital Management first reported a position in Prothena Corp in Q3 2014 and held it in 4 quarters.
  • Highbridge Capital Management's Prothena Corp position peaked at $1.06M in Q3 2015.
  • 146 funds tracked by Wall St. Rank held Prothena Corp as of Q3 2016.

Based on Highbridge Capital Management's 13F filing for Q3 2016, filed 14 Nov 2016.